大洋生物
(003017)
| 流通市值：23.22亿 | | | 总市值：28.15亿 |
| 流通股本：6928.80万 | | | 总股本：8400.00万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 747,305,412.73 | 499,310,379.08 | 248,970,295.2 | 909,955,718.12 |
| 营业收入 | 747,305,412.73 | 499,310,379.08 | 248,970,295.2 | 909,955,718.12 |
| 二、营业总成本 | 668,570,639.15 | 442,861,186.78 | 222,247,645.62 | 844,689,203.2 |
| 营业成本 | 570,929,692.37 | 377,945,296.92 | 191,316,962.53 | 732,057,470.06 |
| 税金及附加 | 6,924,330.72 | 4,418,107.6 | 1,798,408.24 | 7,630,063.11 |
| 销售费用 | 8,192,631.5 | 5,746,198.28 | 2,744,277.15 | 9,791,201.44 |
| 管理费用 | 57,893,992.78 | 39,318,244.97 | 18,878,286.16 | 69,552,319.18 |
| 研发费用 | 27,695,023.89 | 17,273,842.28 | 8,948,093.95 | 28,783,859.27 |
| 财务费用 | -3,065,032.11 | -1,840,503.27 | -1,438,382.41 | -3,125,709.86 |
| 其中:利息费用 | 3,371,603.38 | 2,430,852.05 | 988,783.3 | 6,767,211.56 |
| 其中:利息收入 | 6,441,764.33 | 4,074,837.3 | 2,140,265.22 | 8,847,913.71 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -69,624.24 | 296,228.9 | -371,617.8 | 1,472,424.84 |
| 加:投资收益 | -774,165.39 | -1,121,628.15 | -326,255.33 | -1,107,900.51 |
| 资产处置收益 | 15,787.61 | - | - | 85,131.93 |
| 资产减值损失(新) | -14,055,437.73 | -13,797,792.73 | 496,883.9 | -7,014,898.62 |
| 信用减值损失(新) | -541,569.53 | 118,049.97 | -1,520,197.75 | -1,942,840.05 |
| 其他收益 | 20,554,807.23 | 14,817,071.15 | 7,829,147.85 | 18,609,088.59 |
| 四、营业利润 | 83,864,571.53 | 56,761,121.44 | 32,830,610.45 | 75,367,521.1 |
| 加:营业外收入 | 99,035.05 | 78,630.45 | 26,149.12 | 388,496.97 |
| 减:营业外支出 | 1,883,182.41 | 2,202,276.17 | 1,920,082.03 | 4,113,278.3 |
| 五、利润总额 | 82,080,424.17 | 54,637,475.72 | 30,936,677.54 | 71,642,739.77 |
| 减:所得税费用 | 2,421,380.2 | 4,341,508 | 1,607,729.53 | 7,907,228.56 |
| 六、净利润 | 79,659,043.97 | 50,295,967.72 | 29,328,948.01 | 63,735,511.21 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 79,659,043.97 | 50,295,967.72 | 29,328,948.01 | 63,735,511.21 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 80,036,566 | 50,505,565.27 | 29,343,179.68 | 63,746,331.5 |
| 少数股东损益 | -377,522.03 | -209,597.55 | -14,231.67 | -10,820.29 |
| 扣除非经常损益后的净利润 | 74,983,571.02 | 46,760,916.19 | 29,760,962.87 | 61,167,930.24 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.98 | 0.62 | 0.36 | 0.78 |
| (二)稀释每股收益 | 0.98 | 0.62 | 0.36 | 0.78 |
| 九、综合收益总额 | 79,659,043.97 | 50,295,967.72 | 29,328,948.01 | 63,735,511.21 |
| 归属于母公司股东的综合收益总额 | 80,036,566 | 50,505,565.27 | 29,343,179.68 | 63,746,331.5 |
| 归属于少数股东的综合收益总额 | -377,522.03 | -209,597.55 | -14,231.67 | -10,820.29 |
| 公告日期 | 2025-10-21 | 2025-08-26 | 2025-04-22 | 2025-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |